Tag: new drug

A pharmacist helps a customer understand Foundayo cost and available savings programs
Coupons, Drug Savings, Prescription Drugs, Specialty Drugs
No Comments

How to Afford Foundayo (orforglipron), the First GLP-1 Pill for Weight Loss

Foundayo (orforglipron) is one of the most talked-about new medications of 2026 – and if you’ve been prescribed it, Foundayo cost is probably on your mind. This post explains what Foundayo is and, more importantly, walks through the programs that can help you afford it. What Foundayo is Foundayo (orforglipron) is an oral GLP-1 receptor agonist made by Eli Lilly. According to the FDA, it was approved on April 1, 2026, for adults with obesity, or who are overweight with weight-related medical problems. What makes it notable is that it’s a pill – most GLP-1 medications for weight management are […]

Read More
A patient and oncologist discuss Rasonque cost and treatment support options in a supportive consultation
Cancer, Coupons, Disease Resources, Drug Savings, Prescription Drugs, Specialty Drugs
No Comments

How to Afford Rasonque (daraxonrasib), a New Pancreatic Cancer Treatment

Rasonque (daraxonrasib) is a newly approved treatment for advanced pancreatic cancer — and for patients and families facing this diagnosis, questions about cost can add to an already overwhelming time. This post explains what Rasonque is and walks through the programs that can help with the Rasonque cost. What Rasonque is Rasonque (daraxonrasib) is a once-daily pill made by Revolution Medicines. According to the FDA, it was approved on August 26, 2026, for adults with metastatic pancreatic adenocarcinoma — the most common form of pancreatic cancer — who have already received at least one prior treatment, or who are not […]

Read More

About Us

Welcome to the NeedyMeds Voice! We look forward to presenting you with timely, provocative pieces on healthcare reform, patient advocacy, medication and healthcare access, and other health-related news. Our goals are to educate, enlighten, and elucidate; together, we will try to make sense of the myriad and ongoing healthcare-related changes in the U.S. today.